NOVEL LOW COST ULTRAHIGH THROUGHPUT FLOW CYTOMETER

新型低成本超高通量流式细胞仪

• 批准号: 6443539
• 负责人: GLENN SPAULDING
• 金额: $ 10万
• 依托单位: CLEAR LAKE MEDICAL FOUNDATION, INC.
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-02-15 至 2002-08-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6443539
• 关键词: bioengineering /biomedical engineering; biomedical equipment development; cell sorting; computer program /software; fiber optics; flow cytometry; high throughput technology; imaging /visualization /scanning; immunomagnetic separation; lasers; leukocyte count; light scattering; optical rotation; particle counter; platelets

DESCRIPTION (provided by applicant): A novel low cost ultrahigh throughput flow cytometer was designed to significantly reduce the cost and complexity of diagnostic testing. It is anticipated that the design will enable the transfer of laboratory diagnostic testing to point-of-care testing, while realizing a large cost reduction. The combination of cost reduction and point-of-care testing should improve overall health care, as well as health care in previously underserved communities, rural areas, and third world countries. An instrument will be built to the general specifications for point-of-care testing. Once built, the system and subassemblies will be test for accuracy and variability. Cost and performance improvements will be made throughout the evaluation process. When specifications are met, testing will begin to address a specific health care application.

描述（由申请人提供）：一种新颖的低成本超高通量流 细胞仪的设计目的是显着降低成本和复杂性 诊断测试。预计该设计将实现转移 从实验室诊断测试到现场护理测试，同时实现 成本大幅降低。降低成本和现场护理的结合 检测应改善整体医疗保健以及局部地区的医疗保健 以前服务不足的社区、农村地区和第三世界国家。一个 仪器将按照现场护理的一般规格制造 测试。一旦建成，系统和子组件将进行准确性和可靠性测试 可变性。成本和性能改进将在整个过程中进行 评估过程。当满足规格时，测试将开始解决 特定的医疗保健应用程序。